EVOLUTION OF THE TREATMENT IN PRIMARY IMMUNE THROMBOCYTOPENIA (PTI). PRE AND POST ANALOGOUS ERA OF THROMBOPOIETIN. EXPERIENCE IN OUR CENTRE

被引:0
|
作者
Canovas Gimenez, V [1 ]
Benet Campos, C. [1 ]
Bautista Claver, T. [1 ]
Carcel Corella, P. [1 ]
Gomez Toboso, D. [1 ]
Lopez Martinez, A. [1 ]
Sancho-Tello De Carranza, R. [1 ]
Carrera Merino, M. D. [1 ]
Amigo Garcia, V [1 ]
Mena Rodriguez, F. [1 ]
Alonso Prieto, C. [1 ]
Monzo Castellano, E. [1 ]
Garcia Navarro, I [1 ]
Mas Ochoa, C. [1 ]
Mayans Ferrer, J. R. [1 ]
机构
[1] Hosp Arnau De Vilanova Valencia, Valencia, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PC-311
引用
收藏
页码:226 / 226
页数:1
相关论文
共 9 条
  • [1] ROLE OF SPLENECTOMY IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (PTI). EXPERIENCE IN OUR CENTRE
    Canovas Gimenez, V
    Benet Campos, C.
    Bautista Claver, T.
    Carcel Corella, P.
    Gomez Toboso, D.
    Carrera Merino, M. D.
    Lopez Martinez, A.
    Sancho-Tello De Carranza, R.
    Mayans Ferrer, J. R.
    HAEMATOLOGICA, 2015, 100 : 225 - 225
  • [2] TREATMENT OF REFRACTORY IMMUNE THROMBOCYTOPENIA WITH THROMBOPOIETIN RECEPTOR AGONISTS: OUR EXPERIENCE IN CHILDHOOD
    Zanabili Al-Sibai, J.
    Arias Fernandez, T.
    Palomo Moraleda, M. P.
    Morais Bras, L. R.
    Castanon Fernandez, C.
    Avila Idrovo, L. F.
    Sole Magdalena, A.
    Gonzalez Muniz, S.
    Fernandez Rodriguez, M. A.
    HAEMATOLOGICA, 2017, 102 : 841 - 841
  • [3] Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment
    Mageau, Arthur
    Terriou, Louis
    Ebbo, Mikael
    Souchaud-Debouverie, Odile
    Orvain, Corentin
    Graveleau, Julie
    Lega, Jean-Christophe
    Ruivard, Marc
    Viallard, Jean-Francois
    Cheze, Stephane
    Dossier, Antoine
    Bonnotte, Bernard
    Perlat, Antoinette
    Gobert, Delphine
    Costedoat-Chalumeau, Nathalie
    Jeandel, Pierre-Yves
    Dernoncourt, Amandine
    Michel, Marc
    Godeau, Bertrand
    Comont, Thibault
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (01) : 10 - 17
  • [4] Splenectomy for Primary Immune Thrombocytopenia Revisited at the Era of Thrombopoietin Receptor Agonists: New Insights for an Old Treatment
    Mageau, Arthur
    Terriou, Louis
    Ebbo, Mikael
    Souchaud-Debouverie, Odile
    Orvain, Corentin
    Graveleau, Julie
    Lega, Jean-Christophe
    Ruivard, Marc
    Viallard, Jean-Francois
    Cheze, Stephane
    Dossier, Antoine
    Bonnotte, Bernard
    Perlat, Antoinette
    Gobert, Delphine
    Costedoat-Chalumeau, Nathalie
    Jeandel, Pierre-Yves
    Dernoncourt, Amandine
    Michel, Marc
    Godeau, Bertrand
    Comont, Thibault
    BLOOD, 2021, 138
  • [5] Thrombopoietin receptor agonists for treatment of new and relapsed immune thrombocytopenia in children-A single-centre experience
    Hassan, Eman
    Motwani, Jayashree
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 166 - 166
  • [6] Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center
    Javier Gonzalez, Karla
    Ortiz Zuluaga, Sebastian
    Villegas DaRos, Carolina
    Perez Rodriguez, Pedro
    Cervero Marti, Antonio
    ANNALS OF HEMATOLOGY, 2017, 96 (03) : 507 - 508
  • [7] Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center
    Karla Javier González
    Sebastian Ortiz Zuluaga
    Carolina Villegas DaRos
    Pedro Pérez Rodríguez
    Antonio Cerveró Martí
    Annals of Hematology, 2017, 96 : 507 - 508
  • [8] "On-demand" treatment with Thrombopoietin mimetics as "bridge to recovery" from chemotherapy in chronic immune thrombocytopenia patients with cancer. A single centre experience in nine patients
    Spina, Paolo
    Impera, Stefana
    Todaro, Anna Maria
    Salerno, Marilena
    Floridia, Pietro Michele
    Castagna, Fabrizio
    Consoli, Ugo
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (03) : 400 - 403
  • [9] Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium
    Rovo, Alicia
    Cantoni, Nathan
    Samii, Kaveh
    Ruefer, Axel
    Koenen, Giedre
    Ivic, Sandra
    Cavanna, Davide
    Benz, Rudolf
    PLOS ONE, 2022, 17 (04):